This study measures the impact of Medicaid formulary restrictions on the rate at which patients who failed on a drug therapy for schizophrenia return to the same therapy.
Ryan M. Conrad, PhD
Advertisement
Articles by Ryan M. Conrad, PhD
Advertisement
Latest Updated Articles
- Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens
Published: September 27th 2012 | Updated:
- Do Strict Formularies Replicate Failure for Patients With Schizophrenia?
Published: March 19th 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
2025 Nobel Prize in Medicine Honors Discoveries Behind Regulatory T Cells
2
FDA Expands Roflumilast Use for Atopic Dermatitis to Children Aged 2 to 5 Years
3
Aggressive Therapy Recommendations Following the STRONG-HF Trials: Stephen J. Green, MD
4
Pricing and Insurance Networks in Outpatient Surgery Markets
5
